Faculty Profiles - MATSUO Toshihiko

Papers - MATSUO Toshihiko

Division display 21 - 40 of about 144 ／ All the affair displays >>

Vogt-Koyanagi- Harada disease in pregnancy: Case report and review of 32 patients in the literature. Reviewed

Toshihiko Matsuo, Kasumi Takahashi, Tsunemasa Kondo

Clinical Case Reports 12 ( e8643 ) 1 - 12 2024.3

sarcoidosis-lymphoma 症候群 Invited

松尾俊彦

「別冊日本臨床血液症候群（第3版）IV その他の血液疾患を含めて 29 413 - 417 2024.2

Rare Combination of Abducens Nerve Palsy and Optic Neuritis on the Same Side: Case Report and Review of 8 Patients in Literature. Reviewed

Toshihiko Matsuo, Daisuke Iguchi

Journal of Investigative Medicine High Impact Case Reports 12 ( 23247096231225873 ) 1 - 7 2024.1

Morphometric Analysis of the Eye by Magnetic Resonance Imaging in MGST2-Gene-Deficient Mice. Reviewed

Chaomulige, Toshihiko Matsuo, Kohei Sugimoto, Mary Miyaji, Osamu Hosoya, Masashi Ueda, Ryosuke Kobayashi, Takuro Horii, Izuho Hatada

Biomedicines 12 ( 370 ) 1 - 14 2024.1

[Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation]. Reviewed

Fuminari Fujii, Toshiki Terao, Hisakazu Nishimori, Kentaro Fujii, Toshihiko Matsuo, Tadashi Yoshino, Hiroko Ueda, Tadashi Oyama, Akifumi Matsumura, Kaho Kondo, Chisato Matsubara, Kanako Fujiwara, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Keiko Fujii, Nobuharu Fujii, Ken-Ichi Matsuoka, Yoshinobu Maeda

[Rinsho ketsueki] The Japanese journal of clinical hematology 65 ( 7 ) 622 - 627 2024

Language：Japanese Publishing type：Research paper (scientific journal)

Relapsed and/or refractory (R/R) primary central nervous system lymphoma (PCNSL) has a poor prognosis. A 57-year-old man diagnosed with PCNSL achieved a complete response by high-dose methotrexate-based chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT). The disease was not cured, so he was treated with the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel after the third relapse. However, the disease relapsed again 28 days after CAR T-cell therapy. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) was attempted as curative therapy after bridging with second ASCT and tirabrutinib monotherapy. Although a temporary response was achieved, the disease relapsed 98 days after allo-HSCT. While receiving tirabrutinib for relapse after allo-HSCT, the patient developed acute respiratory failure due to transplant-related toxicity and post-transplant thrombotic microangiopathy. He died 175 days after allo-HSCT. Although various treatments for PCNSL have been investigated in recent years, the treatment strategy for R/R PCNSL has not been established. Further studies are warranted to improve the outcomes of patients with R/R PCNSL.

DOI： 10.11406/rinketsu.65.622

PubMed

researchmap

特集指定難病 Up to Date 網膜色素変性症 Invited Reviewed

松尾俊彦

岡山医学会雑誌 135 ( 3 ) 147 - 151 2023.12

Nontuberculous mycobacterial abscess of lacrimal sac and eyelid debridement: Case report Reviewed

Toshihiko Matsuo, Takehiro Tanaka, Kiyoshi Yamada, Motoko Nose, Yasushi Tanimoto

Clinical Case Reports 11 ( e8364 ) 1 - 6 2023.12

A simple method for culturing Acanthamoeba from soft contact lens at a clinical laboratory of a hospital: Case report of Acanthamoeba keratitis. Reviewed

Toshihiko Matsuo, Motoko Nose

Clinical Case Reports 11 ( e8248 ) 1 - 5 2023.11

Resection of Orbital Myxoma With Magnetic Resonance Imaging Evidence of Ethmoid Sinus Origin: Case Report and Review of 20 Patients in the Literature. Reviewed

Toshihiko Matsuo, Takehiro Tanaka

Journal of Investigative Medicine High Impact Case Reports 11 ( 10.1177/23247096231201013 ) 1 - 6 2023.9

Bilateral lacrimal gland mantle cell lymphoma in 11-year follow-up: case report and review of 48 cases with ocular adnexal presentation in the literature. Reviewed

Toshihiko Matsuo, Takehiro Tanaka, Kazuya Okada, Kenji Notohara, Keiko Fujii, Nobuharu Fujii

Journal of Investigative Medicine High Impact Case Reports 11 ( 23247096231185483 ) 2023.7

Bilateral Optic Neuritis and Hypophysitis With Diabetes Insipidus 1 Month After COVID-19 mRNA Vaccine: Case Report and Literature Review Reviewed

Toshihiko Matsuo, Kohei Okubo, Hirofumi Mifune, Takeshi Imao

Journal of Investigative Medicine High Impact Case Reports 11 ( 23247096231186046 ) 1 - 10 2023.7

ANCA-associated vasculitis with scleritis, corneal melt, and perforation rescued by rituximab: Case report and literature review Reviewed

Toshihiko Matsuo, Sumie Hiramatsu-Asano, Hiroshi Sawachika, Hirotake Nishimura

Clinical Case Reports 11 ( e7595 ) 1 - 8 2023.6

両側涙腺原発マントル細胞リンパ腫に対する末梢血幹細胞移植後10年診た1例

松尾俊彦, 田中健大, 岡田和也, 能登原憲司, 藤井敬子, 藤井伸治

日本リンパ網内系学会会誌 63 126 - 126 2023.6

Revisitng cyptocyanine dye, NK-4, as an old and new drug: review and future perspectives. Reviewed

Shuihui Liu, Toshihiko Matsuo, Takumi Abe

Internnational Journal of Molecular Sciences 24 ( 4411 ) 1 - 14 2023.2

Revisiting Cryptocyanine Dye, NK-4, as an Old and New Drug: Review and Future Perspectives

Shihui Liu, Toshihiko Matsuo, Takumi Abe

International Journal of Molecular Sciences 2023.2

Are Prophylactic Systemic Antibiotics Required in Patients with Cataract Surgery at Local Anesthesia? Reviewed

Toshihiko Matsuo, Masahiro Iguchi, Noriyasu Morisato, Tatsuya Murasako, Hideharu Hagiya

International Journal of Environmental Research and Public Health 19 ( 15796 ) 1 - 8 2022.11

Temporal association of vitreous hemorrhage and hypertension after COVID- 19 mRNA vaccines. Reviewed

Toshihiko Matsuo, Hiroshi Noda

Clinical Case Reports 10 ( e06657 ) 1 - 3 2022.11

Traditional Chinese Medicines and Prescriptions Brought from China to Japan by a Monk (Jianzhen, Japanese: Ganjin): A Historical Review Reviewed

Shihui Liu, Toshihiko Matsuo, Chie Matsuo, Takumi Abe

Compounds 2 ( 4 ) 267 - 284 2022.10

Authorship：Corresponding author Language：English Publishing type：Research paper (scientific journal) Publisher：MDPI AG

(1) Background: Japanese Kampo medicine has its origin in ancient Chinese medicine. In 742, a Tang Dynasty monk named Jianzhen (Ganjin) was invited by Japanese clerics to visit Japan and teach commandments in Buddhism. Because of the dangers of the voyage and also other obstacles, he took 11 years to reach Japan on the sixth voyage and he was blind when he arrived in Japan. He was the first person in China to go to Japan to establish the Buddhism commandments, and he was also the first person in Japan to directly teach traditional Chinese medicine. Until now, there have been few reports in English about the details of the Chinese herbal medicines he brought to Japan, including the types of herbal medicines, pharmacological activities, and formulations. In the review, we systematically and comprehensively summarized Jianzhen’s life from the standpoint of his medical and pharmaceutical knowledge and the types and pharmacological activities of Chinese herbal medicines and prescriptions that were brought to Japan by Jianzhen; (2) Methods: A review was made on the relevant literature written by Chinese, Japanese, and English languages regarding the medical and pharmacological knowledge of Jianzhen, the 36 Chinese herbal medicines brought to Japan by Jianzhen, and the pharmacological and therapeutic effects of these 36 herbal medicines, as well as their formulations; (3) Results: The review of the literature proved that Jianzhen’s prescriptions served as a basis for current herbal medicines (Kampo) in Japan. In the process of the literature search, we found a book entitled Jianshangren (Holy Priest Jianzhen)’s Secret Prescription, which recorded the complete prescription of the 36 traditional Chinese medicines Jianzhen brought to Japan; (4) Conclusions: Jianzhen is one of the ancestors of traditional Chinese medicine/Kampo medicine, and he brought traditional Chinese medicine and medical books to Japan for patients. He made important contributions to the development of traditional Chinese medicine in Japan.

File： compounds-02-00022.pdf

DOI： 10.3390/compounds2040022

researchmap

Diffuse large B-cell lymphoma in the course of systemic sarcoidosis: A case report and review of 30 Japanese patients with sarcoidosis-lymphoma syndrome. Reviewed

Toshihiko Matsuo, Takehiro Tanaka, Rika Omote, Toshiaki Okada, Kenji Notohara, Kazuya Okada

Journal of Clinical and Experimental Hematopathology 62 ( 4 ) 22 - 237 2022.9

Candidate Genes in Testing Strategies for Linkage Analysis and Bioinformatic Sorting of Whole Genome Sequencing Data in Three Small Japanese Families with Idiopathic Superior Oblique Muscle Palsy Reviewed

Toshihiko Matsuo, Chaomulige, Mary Miyaji, Osamu Hosoya, Akira Saito, Kazuyuki Nakazono

International Journal of Molecular Sciences 23 ( 8626 ) 1 - 16 2022.8

Authorship：Lead author Language：English Publishing type：Research paper (scientific journal) Publisher：MDPI AG

Idiopathic superior oblique muscle palsy is a major type of paralytic, non-comitant strabismus and presents vertical and cyclo-torsional deviation of one eye against the other eye, with a large vertical fusion range and abnormal head posture such as head tilt. Genetic background is considered to play a role in its development, as patients with idiopathic superior oblique muscle palsy have varying degrees of muscle hypoplasia and, rarely, the complete absence of the muscle, that is, aplasia. In this study, whole genome sequencing was performed, and single nucleotide variations and short insertions/deletions (SNVs/InDels) were annotated in two patients each in three small families (six patients in total) with idiopathic superior oblique muscle palsy, in addition to three normal individuals in one family. At first, linkage analysis was carried out in the three families and SNVs/InDels in chromosomal loci with negative LOD scores were excluded. Next, SNVs/InDels shared by the six patients, but not by the three normal individuals, were chosen. SNVs/InDels were further narrowed down by choosing low-frequency (<1%) or non-registered SNVs/InDels in four databases for the Japanese population, and then by choosing SNVs/InDels with functional influence, leading to one candidate gene, SSTR5-AS1 in chromosome 16. The six patients were heterozygous for 13-nucleotide deletion in SSTR5-AS1, except for one homozygous patient, while the three normal individuals were wild type. Targeted polymerase chain reaction (PCR) and direct sequencing of PCR products confirmed the 13-nucleotide deletion in SSTR5-AS1. In the face of newly-registered SSTR5-AS1 13-nucleotide deletion at a higher frequency in a latest released database for the Japanese population, the skipping of low-frequency and non-registration sorting still resulted in only 13 candidate genes including SSTR5-AS1 as common variants. The skipping of linkage analysis also led to the same set of 13 candidate genes. Different testing strategies that consisted of linkage analysis and simple unintentional bioinformatics could reach candidate genes in three small families with idiopathic superior oblique muscle palsy.

File： SO palsy WGS final ijms-23-08626.pdf

DOI： 10.3390/ijms23158626

researchmap

　 PREV - NEXT 　

< MATSUO Toshihiko >

Papers - MATSUO Toshihiko